RT @Saffiya_Khan1: Well, @BBCFergusWalsh, as Medical Editor for the BBC, what’s your answer? Why aren’t you reporting on the dangers of re…
RT @CarijnB: Een belangrijke nieuwe publicatie in @NatureMedicine over de lange termijn effecten van een #SARSCoV2 infectie. Het liegt er n…
RT @drseanmullen: 2-year study on 138k COVID patients: Hospitalized patients still face high health risks after 2 years. Non-hospitalized…
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @drseanmullen: 2-year study on 138k COVID patients: Hospitalized patients still face high health risks after 2 years. Non-hospitalized…
RT @MontesinosSanti: 🔬 INVESTIGACIÓN #LongCovid 6️⃣ Millones pacientes ⏱️ 2 años post infec #SARSCoV2 🤧 en #COVID19 LEVE (no hosp): 🔴 ⬆️…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
🔬 INVESTIGACIÓN #LongCovid 6️⃣ Millones pacientes ⏱️ 2 años post infec #SARSCoV2 🤧 en #COVID19 LEVE (no hosp): 🔴 ⬆️ riesgo MUERTE 6 primeros meses 🔴 31% riesgo #COVIDpersistente 🔴 25% ⬇️ CALIDAD VIDA a los 2 años 🔓 @NatureMedicine @zalaly https://t.co/H
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @CarijnB: Een belangrijke nieuwe publicatie in @NatureMedicine over de lange termijn effecten van een #SARSCoV2 infectie. Het liegt er n…
➡️ Der Forschungsbericht/die Studie dazu im Fachjournal "Nature Medicine" https://t.co/mPznRUM4z6
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @Med58ll: Met elke Covid-19 besmetting lopen we risico op LongCovid, vasculaire en neurologische schade. Hoe zijn we eraan toe in 2030?…
➡️ Der Forschungsbericht/die Studie dazu im Fachjournal "Nature Medicine" https://t.co/mPznRUM4z6
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @SGriffin_Lab: How can any government allow let-it-rip? 💔 https://t.co/bD8vg377XY
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @drseanmullen: 2-year study on 138k COVID patients: Hospitalized patients still face high health risks after 2 years. Non-hospitalized…
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
In sum, our study provides a systematic and comprehensive assessment of the risks of 80 prespecified postacute sequelae. Among nonhospitalized individuals. https://t.co/aymaTAjQNr
RT @drseanmullen: 2-year study on 138k COVID patients: Hospitalized patients still face high health risks after 2 years. Non-hospitalized…
RT @VirusesImmunity: For an in-depth explainer, please see this excellent thread by @zalaly 👇🏽
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
It is clear that the burden of health loss will not only impact patients and their quality of life but also potentially contribute to a decline in life expectancy, and may impact labor participation, economic productivity and societal wellbeing. https://
RT @brownecfm: 1. A very important section from this paper: 'The findings that SARS-CoV-2 leads to postacute and long-term health effects…
@beckstwits @AlixG_2 @DallasBanes 8/21/23 study - 138,818 people from hospitalized to those with a few symptoms: 2 yrs later - cardiovascular disorders, neurologic and mental health disorders, metabolic disorders (diabetes and dyslipidemia), kidney disorde
"Mild"
Measures to reduce the risk of postacute and long-term sequelae in people with SARS-CoV-2 infection should remain the foundation of public health policy. https://t.co/aymaTAjQNr
RT @sunsopeningband: If you do not have a diagnosis code to identify PEM/PESE, then you’ll have umpteen studies like this one that mine dia…
RT @mariagallegobl: 🟢 ATENCIÓN, PREGUNTA: 🗣️¿CUÁL ES EL RIESGO SI ME (RE)INFECTO DE COVID? 🗣️¿DURANTE CUÁNTO TIEMPO EXISTE ESE RIESGO?…
RT @Derek_a_Franks: @marwilliamson People don’t get it. Potentially 1-in-3 infections results in debilitating L0NG C0VlD for at least 2 yea…
RT @Perbess: Cuando te digan "es un catarrito", enséñales este artículo sobre #covidpersistente. #LongCovid Secuelas tras 2 años agrupadas…
RT @gorka_orive: Un estudio de seguimiento de pacientes con COVID19 larga demuestra que meses o incluso 2 años tras la infección (con o sin…
Among those hospitalized with COVID-19, risks remain increased at 2 years after SARS-CoV-2 infection for PASC and all organ systems examined. https://t.co/aymaTAjQNr
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @sunsopeningband: If you do not have a diagnosis code to identify PEM/PESE, then you’ll have umpteen studies like this one that mine dia…
RT @sunsopeningband: If you do not have a diagnosis code to identify PEM/PESE, then you’ll have umpteen studies like this one that mine dia…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @bruce_arthur: The real impact of Covid now - and of our failure on mass-scale cleaner indoor air, though it's not clear how big a diffe…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
@tomdimaggio @mehdirhasan If you read the available scientific literature about post-acute sequelae (what happens after initial Covid sickness), you might not be so glib about that. This is a great summary published yesterday in Nature. https://t.co/lD2C
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @CarijnB: Een belangrijke nieuwe publicatie in @NatureMedicine over de lange termijn effecten van een #SARSCoV2 infectie. Het liegt er n…
1/ 🚨https://t.co/tGVHg81nls Look closely at Suppl. Tables 1 &3. The control and C19 grps are VERY different. The latter is sicker+utilizes health care more frequently. Auths "adjust" for these differences (Tbl 2,4), but puts validity in doubt. @
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @DirkHolzinger: @gunnar_heine @nervensystemck @ChanasitJonas @Karl_Lauterbach Dann vielleicht einen Blick auf diese Arbeit aus @NatureMe…
RT @VirusesImmunity: For an in-depth explainer, please see this excellent thread by @zalaly 👇🏽
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @loscharlos: @zalaly @EricTopol @zalaly is doing absolutely incredible work, & understand the stakes of #LongCovid as well as anyone — c…
RT @diafeliz_latin: nature medecineより。 「600万人の調査。コロナ感染から2年後でも死亡や入院のリスクは上昇したまま。 各臓器へのダメージの後遺症も2年以上リスクが上昇。 コロナウイルスによる健康被害が長期的に持続するという長く困難な道を…
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @SukunaBikona7: 以降2年後までリスクは漸減するものの非感染者より上昇していた。 80種類の後遺症のうち、2年後に改善したものの割合は非入院患者では69%、入院患者では35%であった。 https://t.co/z5x4xYAbYk
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @gorka_orive: Un estudio de seguimiento de pacientes con COVID19 larga demuestra que meses o incluso 2 años tras la infección (con o sin…
RT @zalaly: 9/ 🤔 What does this mean? This illustrates the long and arduous journey of dealing with the long-term health consequences of t…
RT @sunsopeningband: If you do not have a diagnosis code to identify PEM/PESE, then you’ll have umpteen studies like this one that mine dia…
RT @drseanmullen: 2-year study on 138k COVID patients: Hospitalized patients still face high health risks after 2 years. Non-hospitalized…
RT @brownecfm: 1. A very important section from this paper: 'The findings that SARS-CoV-2 leads to postacute and long-term health effects…
Wanneer in uw krant/programma, @volkskrant @klokpieter @nrc @trouw @ADnl @Nieuwsuur @op1npo @NPORadio1 @telegraaf @EenVandaag @NOS @BNR @DeHofbar @ZEMBLA ?
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @thelonevirologi: Postacute sequelae of COVID-19 at 2 years https://t.co/h114XN6LN4
RT @GeoRebekah: You know what causes increased risk of cardiac issues? COVID-19 infection. Chew on that, anti vaxxers. https://t.co/oE…
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @Perbess: Cuando te digan "es un catarrito", enséñales este artículo sobre #covidpersistente. #LongCovid Secuelas tras 2 años agrupadas…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @CarijnB: Een belangrijke nieuwe publicatie in @NatureMedicine over de lange termijn effecten van een #SARSCoV2 infectie. Het liegt er n…
RT @drseanmullen: 2-year study on 138k COVID patients: Hospitalized patients still face high health risks after 2 years. Non-hospitalized…
RT @poetricus2: En personas que no estuvieron hospitalizadas durante la fase aguda de COVID (la mayoría) El riesgo de muerte se mantuvo ele…
RT @gorka_orive: Un estudio de seguimiento de pacientes con COVID19 larga demuestra que meses o incluso 2 años tras la infección (con o sin…
RT @zalaly: 6/ What about disability-adjusted life years (DALYs) One DALY equals one lost year of healthy life 🔸 In non-hospitalized 🔹 80…
RT @gorka_orive: Un estudio de seguimiento de pacientes con COVID19 larga demuestra que meses o incluso 2 años tras la infección (con o sin…
RT @SGriffin_Lab: How can any government allow let-it-rip? 💔 https://t.co/bD8vg377XY
RT @KazBowen: 著者による解説。コロナ感染後のいろんな合併症を2年追跡。急性期に入院が必要になった群とする必要になかった群を分けても解析している。入院しなかった(いわゆる軽症)でも感染後90日間は死亡率が上がる。入院のリスクの上昇も2年弱続く。
RT @VirusesImmunity: An important study by @zalaly team on post-acute sequelae of COVID at 2 years. Based on the VA data, while risks of ma…
RT @CarijnB: Een belangrijke nieuwe publicatie in @NatureMedicine over de lange termijn effecten van een #SARSCoV2 infectie. Het liegt er n…
RT @zalaly: 1/ 📣 New from my team in @NatureMedicine In a study of 6 million people, we examined risk trajectories of 80 components of Lon…
RT @Eliesie1: Nieuwe studie v Ziyad Al-Aly en team. Over de continue risico's van long covid. Waarom doet men dit ons en onze kinderen aan,…
RT @LArtdelInfusion: Long COVID is the disease. #MediaPleaseLookUp